Kirk Michel - Jan 5, 2024 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Role
Chairman, Director
Signature
/s/ Kirk Michel
Stock symbol
PBSV
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
4
Date filed
1/9/2024, 08:34 PM
Previous filing
Mar 28, 2023
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBSV Common Stock Options Exercise $15.2K +20K +52.71% $0.76 57.9K Jan 5, 2024 Direct
transaction PBSV Common Stock Tax liability -$15.2K -14.3K -24.75% $1.06 43.6K Jan 5, 2024 Direct F1
holding PBSV Common Stock 341K Jan 5, 2024 By Kema Advisors, Inc. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBSV Stock Option Options Exercise $0 -20K -100% $0.00* 0 Jan 5, 2024 Common Stock 20K $0.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
F2 The reporting person is the sole shareholder of this entity.
F3 The option vested in two equal installments on July 10, 2020 and July 10, 2021.